More Business Wire
View Older Stories View Newer Stories-
CRH Completes LSE Delisting
-
E3 Lithium Set to Begin Operations for Phase 2 of the Demonstration Facility
-
InfluxData and Litmus Partner to Power Scalable Industrial AI at the Edge
-
SynSmart and Amporin Announce Collaboration to Develop Breakthrough Small Molecule Therapeutics for Degenerative Diseases
-
MBRYONICS Announces Further Expansion in Its Customer Base and Manufacturing Facilities to Meet Rapidly Growing Demand
-
ILOS Upsizes Credit Facility to €450 Million With EIG and La Caisse
-
Echodyne Named as Radar System for Trust Automation’s $490M Air Force Counter-UAS Engineering Contract
-
LR Launches New Generation in the "Beauty-Food" Segment
-
LYCRA® ANTISTATIC Fiber Debuts at Techtextil, Bringing Advanced Comfort and Safety to Workwear and Personal Protective Equipment
-
Re: Shareholder Proposals to MIZUHO FINANCIAL GROUP, INC. (TOKYO:8411) and ORIENT CORPORATION (TOKYO:8585), and Launch of the Campaign Website
-
Mon courtier énergie Group Announces Its 2025 Annual Results and Its Revenue for the First Quarter of 2026
-
QAD | Redzone to Showcase AI-Powered Connected Workforce Platform at Hannover Messe 2026
-
QAD | Redzone Brings the Future of Agentic AI in Manufacturing to Hannover Messe 2026
-
Accenture and Avanade Collaborate with Microsoft to Develop Agentic Factory to Help Reduce Manufacturing Downtime
-
SymphonyAI Launches Eight AI Applications Purpose-Built for Energy Asset Reliability and Operational Performance
-
Petronor and H2SITE Partner to Pioneer High-Purity Hydrogen Production in Refining Through Advanced Membrane Technology
-
Mitsubishi Electric to Launch Railway Energy Management Solution Proof of Concept for Krakow Tram Network in Poland
-
SkyDrive Becomes Japan’s First eVTOL Developer to Earn “Approved Design Organization” (ADO) Certification
-
Faraday Future Announces $45 Million in New Financing with a U.S. Institutional Investor to Strongly Support the Execution of Its EAI Robotics & EAI EV Business; Plans to Pursue Long-Term Strategi
-
SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
-
Horse Powertrain Reveals X-Range C15 Direct Drive Powertrain for Hybridizing BEV Platforms
-
Amplitude Research Reveals a Generational AI Trust Gap is Costing Australian Businesses
-
Best’s Market Segment Report: Australia’s Non-Life Insurance Segment Navigating Growth in a Volatile Landscape
-
Synthetic Design Lab Unveils First Advanced Logic-Gated ADC at AACR 2026, Achieving ≥10X Improvement in Targeted Cancer Cell Killing
-
EpiBiologics Doses First Patient with EPI-326 Bispecific Antibody in Global Phase 1 Study for EGFR-Driven Solid Tumors
-
AST SpaceMobile Addresses Today’s Orbital Launch of BlueBird 7 on the New Glenn Launch Vehicle
-
QXO to Acquire TopBuild for $17 Billion
-
Renee Russo named Exit Planner of the Year at 2026 Exit Planning Summit
-
Block Blast! Brings Its Brand to Coachella as Visibility Grows in the U.S.
-
Lundbeck Presents New Data at AAN 2026 Highlighting Real-World Changes in Migraine-Related Cognitive Symptoms After Starting VYEPTI® (eptinezumab-jjmr)
-
Impact Capital Group Releases New Analysis on Real Estate’s Growing Influence on Lower Middle Market M&A Transaction Outcomes
-
Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments
-
HSS Studies Contribute Early Evidence to Help Guide Emerging Perioperative Considerations for Patients Using GLP‑1 Medications
-
Inocras and Broad Institute Researchers Present New TCGA Whole-Genome Cancer Insights, Accelerating Discovery in Cancer Genomics
-
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments
-
Baron & Budd Finalizes $774 Million Settlement With Albertsons in Nationwide Opioid Litigation
-
HSS Presents New Research Leveraging AI to Uncover Insights Related to Pain Risk and Anesthesia Education at ASRA Annual Meeting
-
Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases
-
Deep Fission to Host Community Webinar on Advanced Nuclear Project in Parsons, Kansas
-
The First Chinese Flagship to Truly Challenge BBA High-Performance SUV Has Arrived
-
CORRECTING and REPLACING Mountain Valley MD Announces Appointment of Advisors and Stock Option Grants
-
2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling
-
Nexstar Media Group, Inc., Statement on Preliminary Injunction
-
Faraday Future Announces $45 Million New Financing; Plans to Hold Annual Meeting of Stockholders on May 22 to Seek Approval of Key Proposals Designed to Accelerate EAI Strategy Execution and Protect S
-
Infinity Natural Resources Announces First Quarter Impact of Derivative Contracts
-
Airline Catering Members of UNITE HERE Local 11 Testify at Public Truth Commission on Working Conditions at LAX Facility
-
Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Boston Health AI Secures Its US Footprint Through Implementation with Avicenna Clinics
-
Phillips 66 Announces Quarterly Dividend
-
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product
